Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Immunostimulatory effects of three classes of CpG oligodeoxynucleotides on PBMC from HCV chronic carriers.

Cooper CL, Ahluwalia NK, Efler SM, Vollmer J, Krieg AM, Davis HL.

J Immune Based Ther Vaccines. 2008 Jun 9;6:3. doi: 10.1186/1476-8518-6-3.

2.

Phase 1B, randomized, double-blind, dose-escalation trial of CPG 10101 in patients with chronic hepatitis C virus.

McHutchison JG, Bacon BR, Gordon SC, Lawitz E, Shiffman M, Afdhal NH, Jacobson IM, Muir A, Al-Adhami M, Morris ML, Lekstrom-Himes JA, Efler SM, Davis HL.

Hepatology. 2007 Nov;46(5):1341-9.

PMID:
17929306
3.

Safety, pharmacokinetics and immune effects in normal volunteers of CPG 10101 (ACTILON), an investigational synthetic toll-like receptor 9 agonist.

Vicari AP, Schmalbach T, Lekstrom-Himes J, Morris ML, Al-Adhami MJ, Laframboise C, Leese P, Krieg AM, Efler SM, Davis HL.

Antivir Ther. 2007;12(5):741-51.

PMID:
17713157
4.
5.

CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults: a double-blind phase I/II study.

Cooper CL, Davis HL, Morris ML, Efler SM, Adhami MA, Krieg AM, Cameron DW, Heathcote J.

J Clin Immunol. 2004 Nov;24(6):693-701.

PMID:
15622454
6.

Co-administration of CpG oligonucleotides enhances the late affinity maturation process of human anti-hepatitis B vaccine response.

Siegrist CA, Pihlgren M, Tougne C, Efler SM, Morris ML, AlAdhami MJ, Cameron DW, Cooper CL, Heathcote J, Davis HL, Lambert PH.

Vaccine. 2004 Dec 16;23(5):615-22.

PMID:
15542181
8.

Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine.

Cooper CL, Davis HL, Morris ML, Efler SM, Krieg AM, Li Y, Laframboise C, Al Adhami MJ, Khaliq Y, Seguin I, Cameron DW.

Vaccine. 2004 Aug 13;22(23-24):3136-43.

PMID:
15297066
9.

Designing gene therapy vectors: avoiding immune responses by using tissue-specific promoters.

Weeratna RD, Wu T, Efler SM, Zhang L, Davis HL.

Gene Ther. 2001 Dec;8(24):1872-8.

10.

Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs.

Krieg AM, Wu T, Weeratna R, Efler SM, Love-Homan L, Yang L, Yi AK, Short D, Davis HL.

Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12631-6.

Supplemental Content

Loading ...
Support Center